Any previous cancer should be inactive, and any previous cancer treatment should be complete before starting EGRIFTA WR
Healing : Pain reduction, increased mobility, faster recovery time
And theres a concern among many clinicians that, because BPC-157 seems to influence growth-related pathways, theres a theoretical risk it could spur tumor growth if cancer cells are present
Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH
8 weeks: ~4 vials 12 weeks: ~6 vials 16 weeks: ~8 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 16 weeks (once daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use ~3.0 mL per 10 mg blend vial for reconstitution
To extend stability, peptide solutions are often stored in sterile buffers with a pH around 56 and kept at -20C or colder when appropriate